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The mass spectrometric (MS) and tandem mass spectrometric (MS/MS) behavior of six
nitrocatechol-type glucuronides using atmospheric pressure chemical ionization (APCI) and
electrospray ionization (ESI) was systematically studied, and the effect of operation parameters
on the fragmentations are presented. The positive ion APCI- and ESI-MS spectra showed an
intense protonated molecule and the respective negative ion spectra a deprotonated molecule
with minimal fragmentation. The main fragment ions in the MS/MS spectra of the protonated
and deprotonated molecules were [M 1 H 2 Glu]1 and [M 2 H 2 Glu]2, respectively,
formed by the loss of the glucuronide moiety. The measured limits of detection indicated that
ESI is a significantly more efficient ionization method than APCI in the negative and positive
ion modes for the compounds studied. MS/MS was found to be less sensitive, but more
reliable and simple than MS due to the absence of chemical noise. (J Am Soc Mass Spectrom
1999, 10, 537–545) © 1999 American Society for Mass Spectrometry
Catechol-O-methyltransferase (COMT) is an im-portant enzyme, found in nearly all humantissue. COMT has an important role in inactivat-
ing catecholamines of a physiological origin as well as
of an environmental origin. Levodopa, the most widely
used drug for Parkinson’s disease, is one of the xeno-
biotics metabolized by COMT. The effects of levodopa
can be enhanced by inhibiting COMT. Nitrocatechol
derivatives are potent inhibitors of COMT and some of
them, such as entacapone, may be beneficial when used
together with levodopa and a dopa decarboxylase in-
hibitor in the medical treatment of patients with Par-
kinson’s disease [1].
The most common conjugative pathway in drug
metabolism is glucuronidation. In humans, only two
major metabolites of entacapone are excreted in urine,
namely, the cis-trans isomers of entacapone glucuro-
nide [2]. The glucuronide moiety greatly increases the
water solubility of the conjugated product and thus its
excretion in urine, blood, or bile. Glucuronides are
polar, nonvolatile and thermolabile compounds and
thus are successfully analyzed by liquid chromatogra-
phy (LC). Limitations are mainly due to detection: poor
selectivity or sensitivity of the commonly used detec-
tors in LC. However, when metabolic pathways and
kinetics for the biotransformation reactions of drug
candidates are postulated, the use of highly selective
and sensitive bioanalytical methods might be necessary.
Conjugated products must be identified and quanti-
tated in complex biological matrices, and preferably
without time-consuming separation of analytes.
Mass spectrometry (MS) and tandem mass spectrom-
etry (MS/MS) provide very sensitive and selective
methods for the analysis of drug conjugates [3]. Early
works in the field of MS and MS/MS analyses of
glucuronides have been done using electron impact and
chemical ionization [4], thermospray [5, 6], and fast
atom bombardment [6, 7]. More recently, atmospheric
pressure chemical ionization (APCI) [8–11] and espe-
cially electrospray ionization (ESI) [12–21] have success-
fully been used in these studies. Although glucuronides
can be identified using MS, quantitation is often per-
formed indirectly, by first hydrolyzing conjugates with
acid or enzymes, because there are only few commercial
glucuronides available for calibration. However, indi-
rect methods are time-consuming and not always reli-
able, for example, if the hydrolysis is incomplete.
Due to the lack of commercial reference standards six
nitrocatechol-type glucuronides were enzymatically
synthesized in our department [22] (Figure 1). The
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study of the mass spectrometric behavior of drug con-
jugates is essential when direct quantitative analysis
methods are developed. Although several studies of the
mass spectrometric behavior of glucuronides have been
done [3], there is still a need for systematic studies using
standard compounds, which are preferred to get reli-
able results. The aim of this study was to characterize
the mass spectrometric and tandem mass spectrometric
behavior of synthesized glucuronides using APCI and
ESI ionization. Both methods offer soft ionization which
causes minimal fragmentation, but more informative
spectra can be obtained by tandem mass spectrometry.
Thermolabile conjugates can be readily analyzed by
these methods and interpretation of spectra of mixtures
is simplified. Some preliminary experiments with direct
injection of spiked urine samples using MS and MS/MS
(product ion and a constant neutral loss scanning) were
performed in order to evaluate the possibility to ana-
lyze urine samples without, for example, LC separation.
Experimental
Materials
Acetic acid, acetonitrile, and methanol were of HPLC
grade (Rathburn; Walkerburn, UK) and ammonium
acetate was of analytical-reagent grade (Merck, Darm-
stad, Germany). The conjugates studied [3-O-glucu-
ronides of nitecapone (NG), tolcapone (TG) and E- and
Z-entacapone (EG, EZG), and 1-O- and 2-O-glucu-
ronides of 4-nitrocatechol (1-O-NCG, 2-O-NCG)] were
enzymatically synthesized using liver microsomes from
rats pretreated with Aroclor 1254 (RCS-088/Analabs,
lot No. K040, North Haven, CT) as catalyst. The reaction
mixture contained 50 mM phosphate buffer (pH 7.4), 10
mM magnesium chloride, 1.2–5 mM substrate, 5 mM
excess uridine 59-diphosphate glucuronic acid (UD-
PGA) triammonium salt (Sigma, St. Louis, MO) and 5
mM 1,4-saccharic acid lactone (Sigma). The incubation
time varied from 2 to 20 h and was performed at 37 °C.
The glucuronides were purified by solid-phase extrac-
tion (Bakerbond C18 Polar Plus) and the chemical struc-
tures were confirmed by UV, IR, 1H and 13C NMR
experiments. Water was purified in a Milli-Q water
purification system (Millipore, Molsheim, France).
Samples
Standard solutions of analytes were prepared by dis-
solving an appropriate amount of each compound in
water:acetonitrile (50:50). The samples were diluted to
an appropriate concentration and acetic acid or ammo-
nium acetate was added. Negative ion ESI-spectra were
recorded with samples containing 0.1% of ammonium
acetate and positive ion ESI-spectra with samples con-
taining 0.1% of acetic acid. Additives were not used in
APCI experiments. Spiked urine samples were purified
by solid-phase extraction (SPE) using Waters Sep-Pak
Plus C18-cartridges preconditioned with 1.0 mL of
methanol and 1.0 mL of 0.05 M hydrochloric acid in 2%
Figure 1. Structures of studied nitrocatechol glucuronides.
Table 1. Major operating parameters of the interfaces used
Electrospray parameter Setting Heated nebulizer parameter Setting
Electrospray voltage Discharge current
Positive ion mode 4.9 kV Positive ion mode 3 mA
Negative ion mode 4.2 kV Negative ion mode 3 mA
Orifice voltage Orifice voltage
Positive ion mode 15 V Positive ion mode 20 V
Negative ion mode 30 V Negative ion mode 30 V
Curtain gas flow rate Curtain gas flow rate
Positive ion mode 1.4 L min21 Positive ion mode 1.8 L min21
Negative ion mode 2.0 L min21 Negative ion mode 2.0 L min21
Nebulizer gas flow rate Nebulizer gas pressure 75 psi
Positive ion mode 1.6 L min21 Auxiliary gas flow rate 2.0 L min21
Negative ion mode 2.2 L min21 Vaporizer temperature 400 °C
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methanol. Urine samples (1.0 mL) were acidified with
50 ml of 1 M hydrochloric acid to pH 1 and transferred
to the SPE cartridge, washed with 1.0 mL of 0.002 M
hydrochloric acid and 1.0 mL of water. Analytes were
eluted with 1.5 ml of methanol and dried in a nitrogen
flow. Samples were diluted to 1.0 mL with water and
filtered (Millipore HV 0.45 mm, Nihon Millipore, Yon-
ezawa, Japan).
Instrumentation
The mass spectrometer was a Sciex API 300 triple
quadrupole equipped with ionspray [pneumatically
assisted electrospray (ESI)] and atmospheric pressure
chemical ionization (APCI) interfaces (Sciex, Toronto,
Canada). The major operating parameters of these two
interfaces are listed in Table 1. A micro syringe pump
(Harvard Apparatus; USA) was used for liquid delivery
in ESI-MS and a LKB HPLC pump 2150 (LKB-produkter
AB; Sweden) in APCI-MS. The samples were intro-
duced with a Rheodyne (Cotati, CA, USA) injector. The
injection volumes were 5 and 50 mL and flow rates 5
mL/min and 0.8 ml/min in ESI-MS and APCI-MS,
respectively. The eluent compositions used were the
same as in the corresponding samples. High-purity air
(99.998%) was used as a nebulizing gas in ESI and
APCI. Nitrogen generated with a Whatman 75-720
(Whatman Inc., Haverhill, MA, USA) nitrogen genera-
tor was used as a curtain gas and as a collision gas in
MS/MS experiments.
ESI parameters were optimized with a view to ob-
taining a maximum absolute abundance of [M 2 H]2
or [M 1 H]1 ions using loop injections of entacapone
glucuronide solution (1 mg/mL). The operating param-
eters in APCI were tuned manually with repeated
entacapone glucuronide injections (10 mg/mL). The
collision conditions were optimized by recording prod-
uct ion spectra of protonated or deprotonated mole-
cules of the compounds at collision energies in the
laboratory frame (ELAB) between 5 and 40 eV. The
negative and positive ion mode MS/MS spectra were
recorded at 20 and 15 eV, respectively. ESI-MS/MS
spectra were also recorded with the center-of-mass
collision energies (ECM) at 1.3 and 0.7 eV in negative
and positive ion modes, respectively.
The sample concentrations were 5 mg/mL in the
recordings of the ESI-MS and -MS/MS spectra and 10
mg/ml in the recordings of the APCI-MS and -MS/MS
spectra. The ESI and APCI spectra were recorded by
accumulating 10 and 5 spectra, respectively. The scan
range was m/z 100–600 (1.5 s/scan) for the MS spectra
and m/z 50–20 above the m/z value of the precursor ion
(2.3 s/scan) for the MS/MS spectra. The limits of
detection (S/N ratio 3/1) were determined using mul-
tiple ion monitoring (MIM) in the MS and single reac-
tion monitoring (SRM) in the MS/MS mode. The dwell
time in all these experiments was 40 ms.
Results and Discussion
ESI-MS Spectra
The declustering potential (orifice voltage) was opti-
mized to obtain a maximum absolute abundance of
deprotonated and protonated molecules in the ESI-MS
experiments. The maximum was obtained at a lower
potential difference in positive (10 eV) than in negative
ion mode (30 eV), indicating the higher stability of
Table 2. Negative ion ESI spectra; orifice voltage 30 V
Compound MW




[M 2 H 2 glu]2
(m/z)
EG 481 502 (16) 480 (100) —
EZG 481 502 (17) 480 (100) —
TG 449 — 448 (100) 272 (8)
NG 441 462 (20) 440 (100) —
1-O-NCG 331 352 (17) 330 (100) 154 (10)
2-O-NCG 331 352 (16) 330 (100) 154 (7)
Abbreviations: EG 5 entacapone glucuronide, EZG 5 Z-entacapone
glucuronide, NG 5 nitecapone glucuronide, 1-O-NCG 5 1-O-glucuro-
nide of 4-nitrocatechol, 2-O-NCG 5 2-O-glucuronide of 4-nitrocatechol,
TG 5 tolcapone glucuronide, [M 2 2H 1 Na]2 5 sodium adduct of
glucuronide, [M 2 H]2 5 deprotonated glucuronide, [M 2 H–glu]2 5
fragment ion formed by the loss of the glucuronide moiety.






[M 1 H 2 glu]1
(m/z)
EG 481 504 (10) 482 (100) 306 (16)
EZG 481 504 (2) 482 (100) 306 (12)
TG 449 472 (6) 450 (100) 274 (26)
NG 441 464 (18) 442 (100) 266 (42)
Abbreviations: [M 1 Na]1 5 sodium adduct of glucuronide, [M 1
H]1 5 protonated glucuronide, [M 1 H–glu]1 5 fragment ion formed
by the loss of the glucuronide moiety; the other abbreviations as for
Table 2.




[M 2 H 2 glu]2
(m/z)
EG 481 480 (51) 304 (100)
EZG 481 480 (78) 304 (100)
TG 449 448 (54) 272 (100)
NG 441 440 (100) 264 (70)
1-O-NCG 331 330 (100) 154 (32)
2-O-NCG 331 330 (100) 154 (28)
Abbreviations: see Table 2.








EG 481 482 (99) 306 (27) 347 (100)
EZG 481 482 (100) 306 (11) 347 (66)
TG 449 450 (100) — —
NG 441 442 (100) — —
Abbreviations: see Tables 2 and 3.
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deprotonated molecules. At higher energies com-
pounds fragmentated to deprotonated or protonated
aglycones, decreasing the absolute intensity of the par-
ent ion. Negative and positive ion ESI-MS spectra of the
compounds are presented in Tables 2 and 3, respec-
tively.
The main peak in all the negative ion spectra was a
deprotonated molecule [M 2 H]2. The structures in-
clude two acidic groups, carboxylic acid in the glucuro-
nide part and phenolic hydroxyl group in the aglycone
part. The pKa value of the ionized carboxylate in the
glucuronyl moiety is 3.2 [23] while the pKa value of the
phenolic hydroxyl group in EG and EZG has been
determined to be 4.1 and 4.2, respectively [24]. The
deprotonation site is probably the more acidic carbox-
ylic acid in the glucuronide moiety, but deprotonation
of the phenolic hydroxyl group is also possible. How-
ever, no double charged ions exist in the ESI-MS spectra
of the compounds and thus only one deprotonation site
is suggested.
A weak sodium adduct ion [M 2 2H 1 Na]2 was
detected for all the compounds except for TG. A quite
weak [M 2 H–176]2 ([M 2 H 2 glu]2) fragment ion
was detected for TG, 1-O-NCG and 2-O-NCG but not
for NG, EG or EZG. The [M 2 H 2 glu]2 ion corre-
sponds to deprotonated aglycone formed by the cleav-
age of the glycoside bond and the retention of nega-
tively charged oxygen in the drug moiety. All the
studied compounds are negatively charged at pH 6.7
and thus have high ionization efficiency and giving low
limits of detection (Table 10).
The main peak in the positive ion ESI-MS spectra
was a protonated molecule. The spectra showed also
the fragment ion [M 1 H 2 glu]1 formed as a result of
protonation to the aglycone moiety, followed by a
transfer of hydrogen from the glucuronide part to the
Figure 2. Effect of collision energy on the absolute abundance of
product ions in the negative ion mode. EG 5 entacapone glucuro-
nide, EZG 5 Z-entacapone glucuronide, NG 5 nitecapone gluc-
uronide, 1-O-NCG 5 1-O-glucuronide of 4-nitrocatechol, 2-O-
NCG 5 2-O-glucuronide of 4-nitrocatechol, TG 5 tolcapone
glucuronide.
Figure 3. Effect of collision energy on the absolute abundance of
product ions in the positive ion mode. EG 5 entacapone glucuro-
nide, EZG 5 Z-entacapone glucuronide, NG 5 nitecapone gluc-
uronide, TG 5 tolcapone glucuronide.
Table 6. ESI-MS/MS spectra of the compounds. Collision energy 20 eV in negative and 15 eV in positive ion mode
Compound MW
Negative ion MS/MS spectra (m/z) Positive ion MS/MS spectra (m/z)
Precursor ion
Product ions
[M 2 H 2 glu]2 Precursor ion
Product ions
[M 1 H 2 glu]1
EG 481 480 (60) 304 (100) 482 (7) 306 (100)
EZG 481 480 (68) 304 (100) 482 (10) 306 (100)
TG 449 448 (34) 272 (100) 450 (3) 274 (100)
NG 441 440 (41) 264 (100) 442 (2) 266 (100)
1-O-NCG 331 330 (5) 154 (100) — —
2-O-NCG 331 330 (14) 154 (100) — —
Abbreviations: see Tables 2 and 3.
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aglycone part and cleavage of the glycoside bond with
retention of oxygen in the aglycone moiety. The site of
protonation cannot be determined exactly, since none of
the compounds includes a basic group. However, judg-
ing by the limits of detection (Table 10) with positive
ESI-MS, the ionization efficiency for EG and EZG was
better than that for TG and NG, and 4-nitrocatechol
glucuronides were not detected. This suggests that the
most probable site of protonation is either the nitrile or
the amide group in EG and EZG, and the carbonyl
group in NG and TG. The lack of these functional
groups explains why 4-nitrocatechol glucuronides were
not protonated.
APCI-MS Spectra
The spray performance in the heated nebulizer interface
is controlled by the vaporizer temperature. The vapor-
izer temperature was optimized between 300 and
500 °C with a view to obtaining a maximum absolute
abundance of the protonated or deprotonated molecule
using EZG and EG. The absolute abundances of the
[M 1 H]1 and [M 2 H]2 ions increased up to 450 °C.
Although the absolute abundances of the ions were
greatest at 450 °C, fragmentation was less at 400 °C and
this temperature was chosen as a compromise. Aceto-
nitrile:water (1:1) was chosen as the eluent over meth-
anol due to lower observed background signal. Ammo-
nium acetate (0.1%) and acetic acid (0.1%) were tested
as additives in APCI experiments in the negative and
positive ion mode, respectively, but were found to be
unnecessary since they did not enhance the signal.
The only peaks in negative ion APCI spectra were ions
of [M 2 H]2 and [M 2 H 2 glu]2 (Table 4). The ion
[M 2 H 2 glu]2 was significantly more abundant than in
the corresponding ESI spectra due to the thermal energy
used in the APCI source. In contrast to ESI spectra, no
sodium adducts were found in the APCI spectra.
All positive ion APCI spectra had an abundant [M 1
H]1 ion, which was also the only ion in the spectra of
TG and NG (Table 5). In the spectra of EG and EZG
there were also ions at m/z 306 and 347. The ion at m/z
306 is [M 1 H 2 glu]1 formed by the loss of the
glucuronide group together with proton transfer from
the glucuronide group to the aglycone part. The prod-
uct ion spectrum of the ion at m/z 347 showed a product
ion at m/z 306 formed by the loss of a ketene radical [41
u] with proton transfer to the aglycone. The ion at m/z
306 has the same structure as [M 1 H 2 glu]1. This
indicates that the ion at m/z 347 is formed by the loss of
the 135 u [C4H7O5] species from the glucuronide moi-
ety. This ion was not detected in positive ESI-MS
spectra, suggesting a different site of protonation in
APCI than in ESI. 1-O-NCG and 2-O-NCG were not
ionized under the positive APCI conditions used. This
is due to the lack of basic functional groups and too low
proton affinities of these compounds.
ESI-MS/MS Spectra
Collision energy in the MS/MS experiments was opti-
mized to produce maximum absolute abundance of
product ion formed by the loss of the glucuronide
moiety (176 u) by recording the product ion spectra of
[M 2 H]2 and [M 1 H]1 at different collision energies
(ELAB 5–40 eV) in negative and positive ion mode,
respectively (Figures 2 and 3). In negative ion mode 30
eV was found to produce the maximum abundance of
[M 2 H–glu]2 for EG, EZG, TG and NG. 1-O-NCG and
2-O-NCG dissociated most at 10 and 15 eV, respec-
tively. The maximum absolute abundance of product
ion in positive ion mode was obtained at 20 eV for EG,
at 15 eV for EZG and TG, and at 10 eV for NG.
ESI-MS/MS spectra were recorded at collision energies
of 20 and 15 eV in negative and positive ion mode,
respectively.
The negative ion ESI-MS/MS spectra of the studied
compounds are presented in Table 6. The spectra
Table 7. ESI-MS/MS spectra with same center-of-mass collision energy (1.3 eV in negative and 0.7 eV in positive ion mode)
Compound MW
Negative ion MS/MS spectra (m/z) Positive ion MS/MS spectra (m/z)
Precursor ion
Product ions
[M 2 H 2 glu]2 Precursor ion
Product ions
[M 1 H 2 glu]1
EG 481 480 (29) 304 (100) 482 (28) 306 (100)
EZG 481 480 (25) 304 (100) 482 (51) 306 (100)
TG 449 448 (22) 272 (100) 450 (15) 274 (100)
NG 441 440 (19) 264 (100) 442 (2) 266 (100)
1-O-NCG 331 330 (17) 154 (100) — —
2-O-NCG 331 330 (40) 154 (100) — —
Abbreviations: see Tables 2 and 3.
Table 8. Positive ion ESI-MS/MS spectra of sodium adducts of






EG 1 Na 504 (100) 328 (87)
EZG 1 Na 504 (100) 328 (97)
TG 1 Na 472 (100) 296 (12) 199 (19)
NG 1 Na 464 (100) 288 (53)
Abbreviations: see Table 2.
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showed only one product ion [M 2 H 2 glu]2 corre-
sponding to the deprotonated aglycone. The [M 2
H 2 glu]2 ion is formed by cleavage of the glycoside
bond with elimination of a neutral glucuronide moi-
ety. Negatively charged ether oxygen is retained on
the aglycone. The resulting product is very stable due
to resonance stabilization and no other peaks exist in
negative ion MS/MS spectra at low collision energies.
However, a few additional minor products can be
produced at collision energies higher than 30 eV. The
[glu]2 peak does not exist in the negative ion ESI-
MS/MS spectra, though the charge is at least partly at
the carboxy group of the glucuronide at the pH of 6.7
used. The positional isomers of 4-nitrocatechol gluc-
Figure 4. Negative ion ESI-MS spectra of (a) entacapone gluc-
uronide (m/z 480) in a standard solution (5 mg/mL) and (b) in
urine (20 mg/mL).
Figure 5. Negative ion ESI-MS/MS spectra of entacapone gluc-
uronide (a) in a standard solution (5 mg/mL) and (b) in urine (20
mg/mL). The precursor ion [M 2 H]2 at m/z 480 and the product
ion [M 2 H 2 glu]2 at m/z 304.
Table 9. Negative and positive APCI-MS/MS spectra of the compounds; collision energies 20 eV and 15 eV, respectively
Compound MW
MS/MS spectra (m/z) in negative
ion mode
MS/MS spectra (m/z) in positive
ion mode
Precursor ion Product ion Precursor ion Product ion Product ion
EG 481 480 (61) 304 (100) 482 (11) 347 (55) 306 (100)
EZG 481 480 (42) 304 (100) 482 (6) 347 (14) 306 (100)
TG 449 448 (36) 272 (100) 450 (2) 315 (24) 274 (100)
NG 441 440 (41) 264 (100) 442 (15) — 266 (100)
1-O-NCG 331 330 (3) 154 (100) — — —
2-O-NCG 331 330 (9) 154 (100) — — —
Abbreviations: see Table 2.
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uronide were significantly different in their tendency
to fragmentate; 2-O-NCG was noticeably more stable
than 1-O-NCG (Table 6), which may indicate differ-
ences in their glycoside bond strengths. However,
cis-trans -isomers EG and EZG produced similar
spectra.
Positive ion ESI-MS/MS spectra were recorded at a
collision energy of 15 eV (Table 6). Analogous to
negative ion mode, only one product ion, [M 1 H 2
glu]1, was formed by the loss of the glucuronide moiety
with proton transfer from the glucuronide group to the
aglycone. The product ions [M 1 H 2 glu]1 were
formed at lower collision energies than [M 2 H 2
glu]2. This indicates a more stable glycoside bond in
[M 2 H]2 than in [M 1 H]1, suggesting that the pro-
tonation may partially occur at the glycoside bond.
The fragmentation efficiencies of the compounds
were compared by recording the product ion spectra of
[M 2 H]2 and [M 1 H]1 not only with same collision
energy in the laboratory frame (ELAB) but also with the
same center-of-mass collision energy (ECM). The follow-
ing equation was used for calculations:
ECM 5 ELABmg/~mp 1 mg! (1)
in which mg is the mass of the target gas and mp is the
mass of the parent ion. The results show that, for a
given ECM, fragmentation increases with decreasing
molecular weight (Table 7). This is because the mole-
cules of lower molecular weight have fewer degrees of
freedom. This tendency can be seen in both the negative
and positive ion modes but more clearly in the negative
ion mode.
The ESI-MS/MS spectra of the sodium adduct ions
[M 1 Na]1 were recorded at a collision energy of 15 eV
in positive ion mode (Table 8). The [M 1 Na]1 ions
were found to be noticeably more stable than [M 1 H]1
ions under similar MS/MS conditions. Collisionally
activated dissociation of sodium adducts resulted in
[M 1 Na 2 glu]1 ions. In the spectrum of TG an addi-
tional ion at m/z 199 was found. This is the sodium
adduct of the glucuronide residue [Glu 1 Na]1 formed
by the loss of neutral aglycone from [M 1 Na]1. The
results show that the sodium is most likely attached to
the aglycone moiety, but in the case of TG it is also
attached to the glucuronide moiety.
Figure 6. Negative ion spectra from neutral loss scan of 176 u. (a)
Entacapone- and Z-entacapone glucuronide (m/z 480), tolcapone
glucuronide (m/z 448), nitecapone glucuronide (m/z 440) and 1-O-
and 2-O-glucuronides of 4-nitrocatechol (m/z 330) in standard
solution (5 mg/mL) and (b) in urine (10 mg/mL). The above
mentioned ions are deprotonated molecules.















EG 0.2 2 2.5 2.5 50 50
EZG 0.2 2 2.5 2.5 50 50
TG 0.3 3 10 10 250 250
NG 3 17 10 15 250 300
1-O-NCG 5 — 30 — 25 —
2-O-NCG 3 — 10 — 10 —
Abbreviations: see Table 2.
543J Am Soc Mass Spectrom 1999, 10, 537–545 APCI AND ESI OF NITROCATECHOL GLUCURONIDES
APCI-MS/MS Spectra
APCI-MS/MS spectra in negative and positive ion
mode are summarized in Table 9. The negative ion
APCI-MS/MS spectra of the deprotonated molecules
are similar to the MS/MS spectra recorded using ESI,
showing the same ions with equal intensities. This
similarity indicates similar internal energies of precur-
sor ions in both ESI and APCI interfaces before the
collision. This is because vibrationally cold ions are
formed in an atmospheric pressure ion source [25].
In the positive ion APCI-MS/MS spectra, the same
ions as in the positive ion ESI-MS/MS spectra were
observed, the main product being [M 1 H 2 glu]1.
However, in contrast to the ESI-MS/MS spectra an
additional ion formed by the loss of 135 u was observed
in the APCI-MS/MS spectra of EG, EZG, and TG. This
ion existed also in the APCI-MS spectra of EG and EZG
and was shown to be a fragment of the protonated
molecule by a precursor ion scan. The ion [M 1 H 2
135]1 is formed in the same way as discussed in detail in
the APCI-MS section above and its presence indicates a
different site of protonation in APCI than in ESI.
MS/MS Spectra of Urine Samples
Preliminary experiments with spiked urine samples (10
mg/ml of nitrocatechol glucuronide) were carried out in
order to study the suitability of direct MS analysis of
urine samples without LC separation. Urine itself con-
tains numerous interfering matrix compounds and di-
rect ESI-MS is not reliable (Figure 4). Negative ion mode
ESI-MS/MS experiments performed with direct injec-
tions of spiked urine samples gave the same product
ions as standard solutions. No additional peaks from
the matrix were detected and ESI-MS/MS spectra of
studied compounds in urine were similar to those
obtained in the standard solutions (Figure 5). The
results suggest that LC is necessary if ESI-MS is used,
but MS/MS experiments could be done by direct infu-
sion of urine samples. However, if direct infusion is to
used for quantitative purposes, the method should first
be carefully evaluated.
Also, a neutral loss scan of 176 u was performed on
a urine sample containing a mixture of all studied
nitrocatechol glucuronides (10 mg/mL). This experi-
ment showed the presence of ions derived from 1-O-
and 2-O-NCG, NG, TG, EG, and EZG, but also some
other ions due to other glucuronides in urine, e.g., of
nutritional origin (Figure 6). This suggest that neutral
loss scan experiments could be useful in the screening
of glucuronides in urine samples.
Limits of Detection
The limits of detection (S/N ratio 3/1) were determined
using multiple ion monitoring (MIM) in MS mode and
single reaction monitoring (SRM) in MS/MS mode in
order to later develop the LC-MS method (Table 10).
The samples were introduced via a loop. Negative ion
ESI-MS was found to be more sensitive than the posi-
tive ion mode. However, ESI-MS/MS experiments gave
similar results in both negative and positive ion modes.
These results show that the ionization efficiencies with
EG, EZG, TG, and NG were similar, but the chemical
noise in the positive ion mode was higher than that in
the negative ion mode (data not shown, available from
the authors). The results obtained using APCI-MS/MS
were similar in both the negative and positive ion modes.
ESI-MS/MS was found to be considerably more sensitive
than APCI-MS/MS. This indicates a better ionization
efficiency of the compounds in ESI than APCI.
Conclusion
All of the studied compounds were ionized in negative
but not in positive ion mode and thus negative ion
mode is preferred. ESI is preferred over APCI because it
was found to be remarkably more sensitive and a
smaller sample volume is needed. The negative ion
mode MS/MS was found to produce only one ex-
tremely abundant product ion, providing a very selec-
tive and sensitive method. Though MS/MS was not as
sensitive as MS, it was noticeably more reliable and
simple due to the absence of disturbing chemical noise.
Direct analysis of urine samples using MS/MS might be
possible according to the preliminary experiments per-
formed in this study.
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